Author:
Charlton Rachel A.,McGrogan Anita
Publisher
Springer International Publishing
Reference27 articles.
1. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet Part C Semin Med Genet. 2011;157:175–82.
2. Andrews EB, Yankaskas BC, Cordero JE, et al. Acyclovir in pregnancy registry: six years' experience. The acyclovir in pregnancy registry advisory committee. Obstet Gynecol. 1992;79(1):7–13.
3. Bérard A, Sheehy O. The Quebec pregnancy cohort – prevalence of medication use during gestation and pregnancy outcomes. PLoS One. 2014;9(4):e93870.
4. Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garcia-Finana M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84(6):637–43.
5. Chambers C. The role of teratology information services in screening for teratogenic exposures: challenges and opportunities. Am J Med Genet Part C Semin Med Genet. 2011;157:195–200.